Raymond Press
Rheumatology · San Diego, CANPI 1215991302
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 714 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Amgen at 26.1% of the total. Reporting peaked in 2019 at $5,564 and has fallen 99.7% since, to $18 in 2024.
Across 714 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$1K
- GSK$1K
- Radius Health, Inc.$1K
- UCB, Inc.$1K
- Johnson & Johnson$826
- plus $6K from 26 others
What the payments were for
- Food & beverage$16,42299%
- Education$1231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 212 | $4,326 |
| AbbVie | 46 | $1,312 |
| GSK | 38 | $1,299 |
| Radius Health, Inc. | 45 | $1,254 |
| UCB, Inc. | 46 | $1,088 |
| Johnson & Johnson | 56 | $826 |
| AstraZeneca(2 entities) | 23 | $799 |
| Bristol Myers Squibb | 27 | $698 |
| Mallinckrodt Hospital Products Inc. | 23 | $683 |
| Pfizer | 27 | $595 |
| Mallinckrodt Enterprises LLC | 19 | $464 |
| Boehringer Ingelheim | 15 | $446 |
| Novartis | 11 | $377 |
| Lilly USA, LLC | 20 | $318 |
| E.r. Squibb & Sons, L.L.C. | 10 | $276 |
| Genentech USA, Inc. | 10 | $245 |
| ANI Pharmaceuticals, Inc. | 10 | $233 |
| Actelion Pharmaceuticals US, Inc. | 15 | $231 |
| Sanofi | 4 | $178 |
| Aurinia Pharma U.S., Inc. | 5 | $170 |
| Zyla Life Sciences, Inc. | 27 | $159 |
| Sanofi-aventis U.S. LLC | 7 | $137 |
| Eisai Inc. | 6 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Medexus Pharma, Inc. | 2 | $34 |
| Ultragenyx Pharmaceutical Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Assertio Therapeutics, Inc. | 2 | $27 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| Kaleo, Inc. | 1 | $14 |
| Bioventus LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,545 in reported general payments places this provider in the 80th percentile of 808 rheumatology providers in California.
Other rheumatology in San Diego
- Ara DikranianSan Diego$2.2M
- Arthur MabaquiaoSan Diego$209K
- Kenneth KalunianSan Diego$194K
- Sudhakar TumuluriSan Francisco$2.8M
- Orrin TroumSanta Monica$1.8M
- Robin DoreTustin$1.5M
- Samy MetyasCovina$1.3M
- Rhonda LambertSan Mateo$1.1M
- William ShielMission Viejo$924K
- Mark BoriginiDowney$920K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.